KMCRIC

귀비탕과 그 변방의 만성피로증후군 증상완화에 대한 효용성: 체계적인 문헌고찰.

남동현.

대한한의학방제학회지.

2020

28(2)

199-209.

https://scienceon.kisti.re.kr/srch/selectPORSrchArticle.do?cn=JAKO202016357498272

Chronic fatigue syndrome, Gwibitang, systematic review, meta-analysis.

Objectives : The purpose of this systematic review is to confirm whether Gwibitang is beneficial in chronic fatigue syndrome (CFS) Methods : Clinical trials were searched from databases including Pubmed, Embase, Central Cochrane, CNKI, Wanfang, CQVIP, CiNii, OASIS, Koreamed, and NDSL The eligible study design was limited into randomized controlled trial, quasi-randomized controlled trial and controlled clinical trial The outcomes included general effectiveness as nominal scale, and fatigue severity, insomnia severity and quality of life as interval or ratio scale The meta-analysis and assessment of risk of bias was performed based on the data extracted from the selected trials Results : The results of eight randomized controlled trials (n=596) were included in the meta-analysis The results of the synthesis showed Gwibitang is beneficial substantially for relieving and managing the general symptoms, and its heterogeneity was not in important level (RR 026 [95% CI 017, 039], Z=647, P<000001, I2=0%) Gwibitang was beneficial for alleviating fatigue (SMD -078 [95% CI -127, -030], Z=317, P=0002), but its certainty was low In case of insomnia, too few trials had been found and their risk of bias was substantial, so no conclusions had been brought to Conclusions : We found an evidence that Gwibitang could be beneficial for managing and alleviating main symptoms in CFS patients

없음

Y

영어